PL1742645T3 - Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity - Google Patents

Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity

Info

Publication number
PL1742645T3
PL1742645T3 PL05735983T PL05735983T PL1742645T3 PL 1742645 T3 PL1742645 T3 PL 1742645T3 PL 05735983 T PL05735983 T PL 05735983T PL 05735983 T PL05735983 T PL 05735983T PL 1742645 T3 PL1742645 T3 PL 1742645T3
Authority
PL
Poland
Prior art keywords
electrolytes
compressed pharmaceutical
peg
pharmaceutical compositions
polyethylene glycol
Prior art date
Application number
PL05735983T
Other languages
English (en)
Inventor
Norman Barras
Ian Cox
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of PL1742645T3 publication Critical patent/PL1742645T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL05735983T 2004-04-23 2005-04-25 Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity PL1742645T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0409104.7A GB0409104D0 (en) 2004-04-23 2004-04-23 Compressed pharmaceutical compositions
EP05735983A EP1742645B1 (en) 2004-04-23 2005-04-25 Compressed pharmaceutical compositions comprising peg and electrolytes
PCT/GB2005/001555 WO2005102364A1 (en) 2004-04-23 2005-04-25 Compressed pharmaceutical compositions comprising peg and electrolytes

Publications (1)

Publication Number Publication Date
PL1742645T3 true PL1742645T3 (pl) 2011-06-30

Family

ID=32344298

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10177007T PL2263680T3 (pl) 2004-04-23 2005-04-25 Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity
PL05735983T PL1742645T3 (pl) 2004-04-23 2005-04-25 Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL10177007T PL2263680T3 (pl) 2004-04-23 2005-04-25 Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity

Country Status (22)

Country Link
US (1) US20070298100A1 (pl)
EP (2) EP2263680B1 (pl)
JP (1) JP2007533719A (pl)
KR (1) KR20070001280A (pl)
CN (1) CN1950097A (pl)
AT (1) ATE496626T1 (pl)
AU (1) AU2005235345B8 (pl)
BR (1) BRPI0510175A (pl)
CA (1) CA2561649C (pl)
DE (1) DE602005026117D1 (pl)
DK (2) DK2263680T3 (pl)
ES (2) ES2519540T3 (pl)
GB (1) GB0409104D0 (pl)
IL (1) IL178722A0 (pl)
MX (1) MXPA06011906A (pl)
NO (1) NO20064780L (pl)
PL (2) PL2263680T3 (pl)
PT (2) PT2263680E (pl)
RU (1) RU2006137347A (pl)
SI (2) SI1742645T1 (pl)
WO (1) WO2005102364A1 (pl)
ZA (1) ZA200608496B (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
ES2278537B1 (es) * 2006-01-30 2008-09-16 Laboratorios Casen-Fleet, S.L. Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso.
US8784872B2 (en) * 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
PL2304146T3 (pl) 2008-06-06 2014-07-31 Roto Frank Ag Urządzenie uruchamiające dla okna, drzwi lub tym podobnych
WO2009158667A2 (en) * 2008-06-27 2009-12-30 Comgenrx, Inc. Povidone compositions for wound healing
WO2010123901A1 (en) 2009-04-21 2010-10-28 Bachwich Dale R Colon lavage system
SG176113A1 (en) * 2009-06-03 2011-12-29 Axcan Pharma Inc L-sugar colon cleansing agent and uses thereof
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
RU2012125189A (ru) * 2009-12-07 2014-01-20 Апталис Фарма ЮЭс,Инк., Способ очистки смесей моносахаридов, содержащих ионные примеси
CN101766648B (zh) * 2010-03-02 2012-01-11 舒泰神(北京)生物制药股份有限公司 聚乙二醇电解质颗粒制剂及其制造方法
DE202010012256U1 (de) * 2010-09-07 2010-11-11 Krewel Meuselbach Gmbh Abführmittel
AU2011100528B4 (en) * 2011-05-10 2011-08-25 Norgine Bv Formulations
EA024566B1 (ru) * 2010-11-04 2016-09-30 Норджин Бв Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая
DE202010016235U1 (de) 2010-12-06 2011-05-19 Norgine B.V. Formulierungen
FI9608U1 (fi) * 2010-11-04 2012-03-29 Norgine Bv Formulaatiot
CN103391790B (zh) 2011-01-28 2016-06-15 布伦特里实验室有限公司 用于肠道清洁的方法、组合物以及包装
MX360450B (es) * 2011-01-31 2018-11-01 Norgine Bv Mejoras de y relacionadas con composiciones.
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
CN102133225B (zh) * 2011-03-18 2012-11-21 海南锦瑞制药股份有限公司 一种复方聚乙二醇电解质散剂及其制备方法
JP6240610B2 (ja) * 2011-10-27 2017-11-29 サリックス ファーマシューティカルズ,インコーポレイテッド 電解質下剤
CN102600201B (zh) * 2012-02-07 2014-07-16 舒泰神(北京)生物制药股份有限公司 用于通便和清肠的药物组合物及其制备方法
BR112015005270B1 (pt) 2012-09-11 2022-11-01 Norgine Bv Composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit
EA034234B1 (ru) * 2013-03-15 2020-01-20 Брейнтри Лабораторис, Инк. Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения
EP3137167A4 (en) * 2014-04-29 2017-12-20 Colonaryconcepts LLC Foods, systems, methods, and kits for providing electrolyte replacement
CA2970651C (en) * 2014-12-12 2020-09-29 Ojai Energetics Pbc Microencapsulated cannabinoid compositions
US10350165B2 (en) 2014-12-12 2019-07-16 Ojai Energetics Pbc Methods and systems for forming stable droplets
FR3056109B1 (fr) 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation
CN107028876B (zh) * 2016-10-09 2020-09-29 舒泰神(北京)生物制药股份有限公司 聚乙二醇电解质口服液及其制备方法
ES2966189T3 (es) 2017-07-20 2024-04-18 Solvay Bicarbonato en partículas funcionalizado como agente de expansión, composición polimérica espumable que lo contiene y su uso en la fabricación de un polímero espumado termoplástico
KR20190093490A (ko) 2018-02-01 2019-08-09 주식회사태준제약 장세척 조성물
WO2019151829A1 (ko) * 2018-02-01 2019-08-08 주식회사태준제약 장세척 조성물
CN110433174A (zh) * 2019-07-17 2019-11-12 华南理工大学 一种高依从性的复方聚乙二醇电解质散剂及其制备方法与应用
CN111617102B (zh) * 2020-05-25 2022-05-31 南京金凯木纳米材料有限公司 一种含聚乙二醇的电解质散剂及其制备方法
MX2023004685A (es) * 2020-10-26 2023-06-22 Braintree Laboratories Inc Formulaciones de sales de sulfato para la limpieza del colon.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121663A (en) * 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
US5229132A (en) * 1985-02-22 1993-07-20 Grimberg Georges Serge Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time
AU6196786A (en) * 1985-08-01 1987-03-05 Braintree Laboratories Inc. Low-sodium laxative and lavage formulation
US5273758A (en) * 1991-03-18 1993-12-28 Sandoz Ltd. Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
US6121663A (en) * 1997-05-22 2000-09-19 Advanced Micro Devices, Inc. Local interconnects for improved alignment tolerance and size reduction
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
US6444198B1 (en) * 1999-02-22 2002-09-03 Smithkline Beecham Corporation Effervescent laxatives
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent

Also Published As

Publication number Publication date
DK2263680T3 (en) 2014-12-08
SI1742645T1 (sl) 2011-05-31
US20070298100A1 (en) 2007-12-27
WO2005102364A1 (en) 2005-11-03
EP1742645B1 (en) 2011-01-26
EP2263680A1 (en) 2010-12-22
PT2263680E (pt) 2014-11-19
NO20064780L (no) 2007-01-18
IL178722A0 (en) 2007-02-11
PT1742645E (pt) 2011-04-29
EP1742645A1 (en) 2007-01-17
ES2519540T3 (es) 2014-11-07
CA2561649A1 (en) 2005-11-03
CN1950097A (zh) 2007-04-18
CA2561649C (en) 2014-10-14
AU2005235345B2 (en) 2011-04-14
MXPA06011906A (es) 2007-01-25
SI2263680T1 (sl) 2015-01-30
AU2005235345B8 (en) 2011-05-12
DK1742645T3 (da) 2011-05-09
BRPI0510175A (pt) 2007-10-02
EP2263680B1 (en) 2014-08-27
GB0409104D0 (en) 2004-05-26
ZA200608496B (en) 2008-07-30
PL2263680T3 (pl) 2015-02-27
DE602005026117D1 (de) 2011-03-10
ATE496626T1 (de) 2011-02-15
JP2007533719A (ja) 2007-11-22
ES2361816T3 (es) 2011-06-22
AU2005235345A1 (en) 2005-11-03
KR20070001280A (ko) 2007-01-03
RU2006137347A (ru) 2008-05-27

Similar Documents

Publication Publication Date Title
IL178722A0 (en) Compressed pharmaceutical compositions comprising peg and electrolytes
WO2006105001A3 (en) Lubricant compositions, condom products and methods of making same
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
EP2415760A3 (en) CCR-9 antagonists
WO2007039825A3 (en) Saccharide foamable compositions
CA2525874A1 (en) Pharmaceutical compositions of varenicline
PL1758553T3 (pl) Kompozycje farmaceutyczne zawierające glikol polietylenowy o masie cząsteczkowej niższej niż 600 Daltonów
WO2008036932A3 (en) Compositions and methods comprising boswellia species
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
IL183044A0 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
WO2007044809A3 (en) Albumin-free botulinum toxin based pharmaceutical compositions containing a hyaluronidase and methods of use
WO2007057714A3 (en) Pharmaceutical compositions comprising methotrexate
WO2006052876A3 (en) Insecticidal compositions suitable for use in preparation of insecticidal granular fertilizer and insecticidal formulations
GB0410616D0 (en) Antiperspirant or deodorant compositions
ID28705A (id) Komposisi yang terdiri dari asam askorbat dan pektin
WO2005092362A3 (de) Pharmazeutisches kombinationspräparat enthaltend ein therapeutisches protein
MX2009005205A (es) Conjugado de polietilenglicol-g-csf.
WO2003020265A3 (en) Compositions comprising pectin and ascorbic acid
PL1615656T3 (pl) Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje
IL191560A0 (en) 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same
WO2005072736A3 (en) Stable gabapentin compositions
ATE442057T1 (de) Interessante nährstoff- und organoleptische eigenschaften zeigende lipidische zusammensetzung
TW200511986A (en) Antifungal composition
HRP20040718A2 (en) Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid
WO2004011005A3 (en) Antimicrobial 2, 4-diamino-pteridine derivatives